Abisola Idu, MS, MPH

“I apply well-established and innovative statistical methods to clinical and public health research. My objective is to support, challenge, or capture new findings that influence decisions that can improve health and health care, worldwide."

Abisola Idu, MS, MPH

Collaborative Biostatistician I, Kaiser Permanente Washington Health Research Institute

Abisola.Idu@kp.org
206-287-2893

Curriculum vitae (CV)

Biography

Biostatistician Abisola Idu, MS, MPH, is interested in research that investigates the effectiveness and efficacy of treatment in pharmacoepidemiologic studies. She has a broad range of interest in research with a strong motivation to investigate the health challenges of malaria, obesity, cancer, heart disease, and maternal health.

Ms. Idu began her contributions to clinical and public health research through her academic training at the University of Texas Health Science Center, School of Public Health. She further got rigorous research experience by being a part of the leukemia, lymphoma, and cancer prevention research team at The University of Texas M.D. Anderson Cancer Center in 2015. She has been a biostatistician at Kaiser Permanente Washington Health Research Institute's Biostatistics Unit since 2018.

Ms. Idu looks forward to using her expertise in application of epidemiological principles and surveillance methodologies at KPWHRI. She has an in-depth knowledge of the ICH-GCP, FDA, IRB policies, regulations, and guidelines and plans to use her skills and background to implement epidemiologic study designs in clinical research studies.

Research interests and experience

Cancer

Efficacy and safety of therapies; association between genetic variability and survival outcomes
Obesity

Role of nutritional, psychological and lifestyle factors; obesity prevention and control
Heart Disease

Role of aging, nutritional and lifestyle factors; Intervention strategies for prevention and disease control
Maternal Health

Association between social, behavioral and clinical factors and maternal and infant outcomes
Malaria

Malaria prevention and control; development of vaccines; availability and accessibility to malaria treatment
Women's Health
M ental Health
Biostatistics
Social Determinants of Health
Vaccines & Infectious Diseases
Cardiovascular Health

Recent publications

Akosile M, Pierce S, Brandt M, Verstovsek S, Borthakur G, Kantarjian H, Ravandi F, Wierda W, Garcia-Manero G, Daver N, Kadia T, Burger JA, Pemmaraju N, Jabbour E, Cortes J. Survival impact of patients (pts) with chronic myeloid leukemia (CML) due to failure from the use of one or more tyrosine kinase inhibitors (TKI). Blood, 126(23), 1587. Accessed December 11, 2017. Retrieved from http://www.bloodjournal.org/content/126/23/1587. PubMed

Boddu P, Garcia-Manero G, Ravandi F, Borthakur G, Jabbour E, DiNardo C, Jain N, Daver N, Pemmaraju N, Anderlini P, Parmar S, Kc D, Akosile M, Pierce SA, Champlin R, Cortes J, Kantarjian H, Kadia T. Clinical outcomes in adult patients with aplastic anemia: a single institution experience Am J Hematol. 2017 Dec;92(12):1295-1302. doi: 10.1002/ajh.24897. Epub 2017 Sep 25. PubMed

Yu L, Tu M, Cortes J, Xu-Monette ZY, Miranda RN, Zhang J, Orlowski RZ, Neelapu S, Boddu PC, Akosile MA, Uldrick TS, Yarchoan R, Medeiros LJ, Li Y, Fajgenbaum DC, Young KH. Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease. Blood. 2017 Mar 23;129(12):1658-1668. doi: 10.1182/blood-2016-11-748855. Epub 2017 Jan 18. PubMed